EN DE
Watch Inix Technologies Holdings Bhd for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Inix Technologies Holdings Bhd (0094) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Inix Technologies Holdings Bhd stock MYR 0.01, price MYR 0.01, upside +1.0%, quality 39 out of 100. Rating: fairly valued. The value is an estimate: none of our valuation models currently carries, it draws on revenue and assets compared with similar companies. Updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Healthcare MY · ISIN MYQ0094OO001

IT Inix Technologies Holdings Bhd logo Thin data Nov 10, 2026

Inix Technologies Holdings Bhd

0094 · KLSE
Low Priority

The stock costs about what our calculation considers fair.

Fair value 0.0051 MYR · Fairly valued
Mixed Growth (revenue 5y +46.8 %/yr in MYR)
Revenue last quarter 19% below a year ago.
Quality 39/100
Loss-making · -20.8% net margin (TTM)
Negative free cash flow
Trails peers (3/9)
Narrow moat 10/100 · thin data
Thin data
Estimate⚠ Thinly traded
Watch Inix Technologies Holdings Bhd for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

0.0725 MYR 0.0050 MYR Fair Value 0.0051 MYR May 2021 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 10, 2026.

How to read this chart

60‑month range 0.0050 MYR – 0.0725 MYR · fair‑value band 0.0050 MYR – 0.0051 MYR · the 0.0050 MYR price screens below the 0.0051 MYR fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 10, 2026.

Follow Inix Technologies Holdings Bhd in your weekly email

Every Wednesday you see whether Inix Technologies Holdings Bhd is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Zen Tech International Berhad, an investment holding company, engages in the provision of software development, system integration, and information technology management consultancy and other related professional services in Malaysia. The company operates through E-commerce and Glove segments.

Show moreShow less

It also manufactures rubbers gloves. The company was formerly known as Inix Technologies Holdings Berhad and changed its name to Zen Tech International Berhad in June 2022. Zen Tech International Berhad was incorporated in 2003 and is based in Kuala Lumpur, Malaysia.

Stock analysis

Inix Technologies Holdings Bhd (0094) currently trades at 0.0050 MYR, while our estimate is 0.0051 MYR, so the stock looks roughly fairly valued today (gap 1.0%).

Show more

Valuation

None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Scenario range: 0.0050 MYR (bear) to 0.0051 MYR (bull), the price of 0.0050 MYR sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 39/100 (below-average quality), in the Healthcare sector.

Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.

Inix Technologies Holdings Bhd reported revenue of 54.9M MYR in FY2025 versus 18.2M MYR in FY2021, a compound +31.7%/yr. Reported net income was −4.9M MYR in FY2025.

Key figures

Market cap 15.8M MYR (≈ $3.9M) Micro · P/S ratio 0.30 · EPS (TTM) −0.0100 MYR · Net margin −8.9% · Return on equity −20.0% · Return on assets (EBIT) −13.4% (5-year average) · Operating margin −16.4% · Revenue (TTM) 53.0M MYR.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).

What moves the price

The share trades about 50% below its 52-week high and at its 52-week low, currently below its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −45% fair-value upside, at 1%, 0094 screens cheaper than that median.

Fair Value

Bear 0.0050 MYR Fair Value 0.0051 MYR Bull 0.0051 MYR
Price 0.0050 MYR · Upside +1.0%
Estimate. None of our valuation models currently carries for this company, usually because of losses or heavy investment. The estimate draws on revenue and assets compared with similar companies and is less precise than a model-based fair value.

Quality Score breakdown

Overall quality 39/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 13
How much profit the company makes from its sales and capital
Quality Growth 83
Are margins and returns getting better?
Cashflow 16
Do the profits arrive as real cash?
Financial strength 50
Debt, balance sheet and risk of trouble
Investment 53
Does it invest with discipline instead of growing at any price?
Low Volatility 33
How calm the share price moves, does not count
Price momentum 40
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 17
Distance to the 52-week high, does not count
New shares 45
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 36/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+11.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+27.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+46.8%
Start year 2020 (pandemic). Over 10 years: +26.5% a year
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+26.5%
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−41.7% (2020) → −11.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch 0094, get fair value alerts →

Compare Inix Technologies Holdings Bhd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 196 stocks

Beats the industry median on 3/8 measures
Overall it trails its industry peers.
Valuation
Quality Score 39 · Bottom 25%
Fair Value upside +1.0% · Above median
Profitability
Return on assets −6.6% · Bottom 25%
Net margin (12 months) −20.8% · Bottom 25%
Operating margin (12 months) −16.4% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) −19.2% · Bottom 25%

Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper

P/B 0.26× · Cheapest 25%
P/S (12 months) 0.30× · Cheapest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)35 · sector 21
FUTURE (revenue growth)0 · sector 40
PAST (return on equity)0 · sector 26
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Solventum Corporation SOLV $90.08 $131.27 +46% vs 0094
EssilorLuxottica Société anonyme EL €187.60 €196.22 +5% vs 0094
Intuitive Surgical, Inc ISRG $450.04 $353.90 −21% vs 0094
Medline Inc MDLN $40.91 $28.59 −30% vs 0094
Alcon Inc ALC CHF 61.88 CHF 34.06 −45% vs 0094
Becton, Dickinson and Company BDX $212.61 $97.80 −54% vs 0094
Straumann Holding STMN CHF 106.85 CHF 45.50 −57% vs 0094
West Pharmaceutical Services, Inc WST $412.55 $139.22 −66% vs 0094
Sartorius Stedim Biotech S.A DIM €223.40 €54.82 −75% vs 0094
Sartorius Aktiengesellschaft SRT €227.00 €42.50 −81% vs 0094

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low StocksStocks for 2027: Large Companies Below Fair Value

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Inix Technologies Holdings Bhd: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Inix Technologies Holdings Bhd Fair Value". https://www.fairvalue-calculator.com/stock/0094.KLSE

Frequently asked questions

Is Inix Technologies Holdings Bhd (0094) overvalued or undervalued?
As of Nov 10, 2026, our estimate of fair value is 0.0051 MYR versus a price of 0.0050 MYR, about +1% upside (fairly valued).
What is the fair value of 0094?
Our estimate for Inix Technologies Holdings Bhd is 0.0051 MYR (as of Nov 10, 2026), built from audited fundamentals. The current price: 0.0050 MYR.
What is the quality score of 0094?
Inix Technologies Holdings Bhd has a Quality Score of 39/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Inix Technologies Holdings Bhd (0094)?
Our calculated price target is the estimate of 0.0051 MYR (as of Nov 10, 2026). Cautious scenario 0.0050 MYR, optimistic scenario 0.0051 MYR. It is an estimate from revenue and assets compared with similar companies, because none of our valuation models currently carries, not an analyst target.
What is the Inix Technologies Holdings Bhd stock forecast for 2026?
Our estimate puts fair value at 0.0051 MYR, about +1% upside versus a price of 0.0050 MYR (fairly valued). Cautious scenario 0.0050 MYR, optimistic scenario 0.0051 MYR. The calculation is refreshed regularly with new filings.
What is the revenue of Inix Technologies Holdings Bhd (0094)?
Inix Technologies Holdings Bhd reported trailing-twelve-month revenue of about 53.0M MYR (latest available figure, as of Nov 10, 2026).
What is the intrinsic value of Inix Technologies Holdings Bhd (0094)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Inix Technologies Holdings Bhd it is 0.0051 MYR per share (as of Nov 10, 2026), against a price of 0.0050 MYR.
Is Inix Technologies Holdings Bhd stock overvalued or undervalued in 2026?
As of Nov 10, 2026, 0094 trades below its calculated fair value: price 0.0050 MYR, fair value 0.0051 MYR, a gap of about +1% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 0094?
No. The price is what the market pays today (0.0050 MYR); the fair value is what the company's own numbers justify (0.0051 MYR). For Inix Technologies Holdings Bhd the two are 0.0000 MYR per share apart. That gap is exactly why we show both numbers side by side.
How much is Inix Technologies Holdings Bhd worth?
The market values Inix Technologies Holdings Bhd at about 15.8M MYR (market capitalisation, as of Nov 10, 2026). Per share that is 0.0050 MYR; our models calculate a fair value of 0.0051 MYR per share.
What do the bullish and bearish scenarios say about 0094?
Our models span a range for Inix Technologies Holdings Bhd: cautious scenario 0.0050 MYR, base 0.0051 MYR, optimistic 0.0051 MYR per share (as of Nov 10, 2026, price 0.0050 MYR). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Inix Technologies Holdings Bhd (0094)?
Balance-sheet figures for Inix Technologies Holdings Bhd (as of Nov 10, 2026): return on equity −20.0%. They feed the Quality Score of 39/100, which measures business quality independently of the share price.
How far is 0094 from its 52-week high?
Inix Technologies Holdings Bhd trades at 0.0050 MYR, about 50% below its 52-week high of 0.0100 MYR and at the low of 0.0050 MYR (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of 0.0051 MYR is for.
Which stocks are comparable to Inix Technologies Holdings Bhd?
From the same area (Healthcare) we also value Intuitive Surgical, Inc, EssilorLuxottica Société anonyme, Becton, Dickinson and Company, Medline Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Inix Technologies Holdings Bhd stock attractive at the current price?
The data as of Nov 10, 2026: price 0.0050 MYR, calculated fair value 0.0051 MYR (+1%), Quality Score 39/100. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
Is it still worth investing in stocks now?
The global stock market currently sits 15.1% above its aggregate fair value. Inix Technologies Holdings Bhd currently trades 1% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Inix Technologies Holdings Bhd (0094)?
The closing price on Nov 6, 2026 was 0.0050 MYR. Our estimate is 0.0051 MYR, about +1% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Inix Technologies Holdings Bhd right now?
The price sits close to our fair value, market and models broadly agree here, little valuation tension. The models converge in a tight band (0.0050 MYR to 0.0051 MYR), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.

Key figures of Inix Technologies Holdings Bhd

How large is the market capitalisation of Inix Technologies Holdings Bhd (0094)?
The market capitalisation of Inix Technologies Holdings Bhd is 15.8M MYR (≈ $3.9M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Inix Technologies Holdings Bhd (0094)?
The price-to-sales ratio of Inix Technologies Holdings Bhd is 0.30 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Inix Technologies Holdings Bhd (0094)?
Earnings per share at Inix Technologies Holdings Bhd are −0.0100 MYR. Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Inix Technologies Holdings Bhd (0094)?
The net margin of Inix Technologies Holdings Bhd is −8.9% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Inix Technologies Holdings Bhd (0094)?
The return on equity (ROE) of Inix Technologies Holdings Bhd is −20.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Inix Technologies Holdings Bhd (0094)?
On an EBIT basis the return on assets of Inix Technologies Holdings Bhd is −13.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Inix Technologies Holdings Bhd (0094)?
The operating margin of Inix Technologies Holdings Bhd is −16.4% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Inix Technologies Holdings Bhd (0094)?
Revenue at Inix Technologies Holdings Bhd is growing −19.2% versus a year earlier (3y avg +27.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Inix Technologies Holdings Bhd (0094) generate?
The free cash flow of Inix Technologies Holdings Bhd is −38.0K MYR (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net debt does Inix Technologies Holdings Bhd (0094) carry?
The net debt of Inix Technologies Holdings Bhd is 2.3M MYR (fiscal year 2025). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed

Watch Inix Technologies Holdings Bhd in the live analysis

One click puts Inix Technologies Holdings Bhd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.